It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2017.
2017 | Hyderabad, Telangana, India | ActiveQren Lifesciences Private Limited, a active private limited company, was established on 11 October 2017 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24304TG2017PTC119997. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ravi Kiran Lolugu (Director), Manoj Kumar Bishoyi (Director), Garikapati Vijaya Nirmala (Director). Past directors included Ramanjaneyulu Bajantri, Ravi Kiran Lolugu, Garikapati Vijaya Nirmala. It holds ₹5.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6-3-852/2/B/11, Ground Floor Aparajita Colony, Lalbangala, Ameerpet, Hyderabad, Telangana, 500016.
U24304TG2017PTC119997
119997
11 October 2017
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Qren Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Kiran Lolugu | Director | 10 Jan 2018 | Current |
| Manoj Kumar Bishoyi | Director | 11 Oct 2017 | Current |
| Garikapati Vijaya Nirmala | Director | 10 Mar 2018 | Current |
| Kapuluri Nagaratnam | Director | 20 Apr 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Jan 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Qren Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 22.15% increase. The company also saw a substantial improvement in profitability, with a 18.9% increase in profit. The company's net worth Soared by an impressive increase of 12.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Qren Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 May 2025 | Others | ₹5.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Qren Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Qren Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qren Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 5.50 M with Charge ID 101114149 was registered on 16 May 2025. was documented.
Progress on Qren Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Qren Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on Kapuluri Nagaratnam was appointed as a Director was appointed as a Director on 20 Apr 2018 & has been associated with this company since 7 years 7 months . was documented.
The activity Garikapati Vijaya Nirmala was appointed as a Director was appointed as a Director on 10 Mar 2018 & has been associated with this company since 7 years 9 months . was completed.
Ravi Kiran Lolugu was appointed as a Director was appointed as a Director on 10 Jan 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.
The CIN of Qren Lifesciences Private Limited is U24304TG2017PTC119997.
Qren Lifesciences Private Limited is headquartered at 6-3-852/2/B/11, Ground Floor Aparajita Colony, Lalbangala, Ameerpet, Hyderabad, Telangana, 500016.
Qren Lifesciences Private Limited was incorporated on 11 October 2017.
The current directors of Qren Lifesciences Private Limited are
The primary industry of Qren Lifesciences Private Limited is Trade.
Qren Lifesciences Private Limited is unlisted.
The authorized capital of Qren Lifesciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Qren Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX